ENDRA Life Sciences Cash Conversion Cycle 2011-2026 | NDRA

Annual Cash Conversion Cycle ENDRA Life Sciences

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-1.24 K	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-1.24 K	-1.24 K	-1.24 K

Quarterly Cash Conversion Cycle ENDRA Life Sciences

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	138	-	-452	-1.03 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
138	-1.03 K	-449

Cash Conversion Cycle of other stocks in the Diagnostics research industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	50.2	-	-6.23 %	$ 30.6 M	Germany
Co-Diagnostics CODX	299	$ 6.19	-	$ 182 M	USA
DexCom DXCM	133	$ 67.4	-	$ 26 B	USA
Burning Rock Biotech Limited BNR	149	$ 23.3	-	$ 251 M	China
Akumin AKU	36.1	-	-17.87 %	$ 25.9 M	Canada
Biocept BIOC	78.1	-	-13.05 %	$ 7.29 M	USA
Guardant Health GH	49.1	$ 110.17	-	$ 13.5 B	USA
Accelerate Diagnostics AXDX	364	-	-61.36 %	$ 2.46 M	USA
Castle Biosciences CSTL	45.9	$ 39.34	-	$ 1.09 B	USA
BioNano Genomics BNGO	225	$ 1.58	-	$ 2.01 M	USA
Illumina ILMN	142	$ 141.07	-	$ 22.4 B	USA
Chembio Diagnostics CEMI	111	-	0.22 %	$ 16.8 M	USA
Lantheus Holdings LNTH	90.9	$ 67.56	-	$ 4.68 B	USA
Global Cord Blood Corporation CO	184	-	-	$ 399 M	China
Genetic Technologies Limited GENE	11 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	142	-	0.12 %	$ 80.1 M	China
PRA Health Sciences, Inc. PRAH	1.21 K	-	-	$ 10.7 B	USA
National Research Corporation NRC	33	$ 19.72	-	$ 484 M	USA
Natera NTRA	81.5	$ 234.31	-	$ 23.1 B	USA
CareDx, Inc CDNA	76.4	$ 17.13	-	$ 921 M	USA
Danaher Corporation DHR	83.5	$ 238.37	-	$ 174 B	USA
DermTech DMTK	66.7	-	-11.32 %	$ 2.94 M	USA
Pacific Biosciences of California PACB	149	$ 1.94	-	$ 492 M	USA
DarioHealth Corp. DRIO	207	$ 12.16	-5.74 %	$ 345 M	Israel
Anixa Biosciences ANIX	385	$ 3.38	-	$ 108 K	USA
Koninklijke Philips N.V. PHG	89	$ 29.58	-	$ 20 B	Niderland
Personalis PSNL	-11.5	$ 8.1	-	$ 480 M	USA
Enzo Biochem ENZ	154	-	-8.98 %	$ 14.8 K	USA
QIAGEN N.V. QGEN	122	$ 48.29	-0.01 %	$ 10.8 B	Niderland
Exact Sciences Corporation EXAS	130	$ 102.11	-	$ 18.9 B	USA
Fulgent Genetics FLGT	42.4	$ 27.85	-	$ 842 M	USA
Aspira Women's Health AWH	-38.7	-	-6.19 %	$ 10.5 M	USA
Thermo Fisher Scientific TMO	69.8	$ 618.86	-	$ 236 B	USA
Trinity Biotech plc TRIB	136	$ 0.73	0.03 %	$ 61.9 M	Irlanda
Twist Bioscience Corporation TWST	83.6	$ 35.32	-	$ 2.11 B	USA
Charles River Laboratories International CRL	67.7	$ 220.91	-	$ 11.4 B	USA
Heska Corporation HSKA	138	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	104	-	-20.0 %	$ 1.06 M	USA
Mettler-Toledo International MTD	63.7	$ 1 485.12	-	$ 31.5 B	Schweiz
IQVIA Holdings IQV	78	$ 242.41	-	$ 43.9 B	USA
Neogen Corporation NEOG	150	$ 9.62	-	$ 2.09 B	USA
Quest Diagnostics Incorporated DGX	38.6	$ 174.44	-	$ 19.4 B	USA
Biodesix BDSX	41.7	$ 5.46	-	$ 708 M	USA
Laboratory Corporation of America Holdings LH	39.8	$ 251.81	-	$ 21.1 B	USA